Is EDNSF or JNJ a better dividend investment in 2026?

EDNSF currently yields 5714.29% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: EDNSF offers higher current income.

What is the dividend yield difference between EDNSF and JNJ?

EDNSF has a forward dividend yield of 5714.29% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 5712.16 percentage points.

Home › Compare › EDNSF vs JNJ

EDNSF vs JNJ: Dividend Comparison 2026

EDNSF yields 5714.29% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EDNSF wins by $228153224412509.56M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EDNSF

● Live price

5714.29%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$228153224412509.59M

Annual income

$220,560,399,839,122,060,000.00

Full EDNSF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — EDNSF vs JNJ

📍 EDNSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EDNSF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EDNSF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EDNSF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EDNSF

Annual income on $10K today (after 15% tax)

$485,714.29/yr

After 10yr DRIP, annual income (after tax)

$187,476,339,863,253,750,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, EDNSF beats the other by $187,476,339,863,253,750,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EDNSF + JNJ for your $10,000?

EDNSF: 50%JNJ: 50%

100% JNJ50/50100% EDNSF

Portfolio after 10yr

$114076612206254.81M

Annual income

$110,280,199,919,561,030,000.00/yr

Blended yield

96.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EDNSF

No analyst data

Altman Z

2.2

Piotroski

4/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EDNSF buys

JNJ buys

No recent congressional trades found for EDNSF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEDNSFJNJ

Forward yield	5714.29% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$228153224412509.59M ✓	$30.3K
Annual income after 10y	$220,560,399,839,122,060,000.00 ✓	$4,689.40
Total dividends collected	$227641622319776.13M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: EDNSF vs JNJ ($10,000, DRIP)

Year	EDNSF Portfolio	EDNSF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$582,129	$571,428.57	$10,592	$272.30	+$571.5K → EDNSF
2	$31,711,186	$31,088,308.22	$11,289	$357.73	+$31.70M → EDNSF
3	$1,616,661,128	$1,582,730,159.44	$12,123	$472.89	+$1616.65M → EDNSF
4	$77,139,944,357	$75,410,116,950.20	$13,141	$629.86	+$77139.93M → EDNSF
5	$3,445,379,409,484	$3,362,839,669,021.90	$14,408	$846.81	+$3445379.40M → EDNSF
6	$144,058,436,084,716	$140,371,880,116,567.28	$16,021	$1,151.60	+$144058436.07M → EDNSF
7	$5,639,412,164,337,400	$5,485,269,637,726,755.00	$18,122	$1,588.22	+$5639412164.32M → EDNSF
8	$206,716,597,857,094,600	$200,682,426,841,253,570.00	$20,930	$2,228.20	+$206716597857.07M → EDNSF
9	$7,096,097,732,137,874,000	$6,874,910,972,430,782,000.00	$24,792	$3,191.91	+$7096097732137.85M → EDNSF
10	$228,153,224,412,509,600,000	$220,560,399,839,122,060,000.00	$30,274	$4,689.40	+$228153224412509.56M → EDNSF

EDNSF vs JNJ: Complete Analysis 2026

EDNSF — Stock

Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products. In addition, the company provides human health products comprising head-lice treatment products, fragrances, deodorants, wound-care products, food flavorings, odor neutralizers, and active ingredient supply/delivery products. The company was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

Full EDNSF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this EDNSF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EDNSF vs SCHD EDNSF vs JEPI EDNSF vs O EDNSF vs KO EDNSF vs MAIN EDNSF vs ABBV EDNSF vs MRK EDNSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.